Abstract 2127P
Background
Yoga has gained more attention worldwide in the last decade and shown the potential to improve physiological and psychological health in various disease conditions. Studies on breast cancer (BC) survivors showed mild to moderate effects within one-month to six-month on various parameters. Cancer treatment-related side effects are often related with functional as well as symptomatic scales. Therefore, we have conducted a randomized control study to find out the effect of long-term yogic intervention on symptom and functional scale in patients undergoing treatment.
Methods
This study was approved by the institutional ethics committee. The current study consisted of 96 BC stage II/III patients receiving cancer treatments who were randomly divided into two groups: Group-I (non-yoga) and Group-II (yoga). Group-II was advised to perform yoga 5 days per week for 48 weeks and was monitored regularly by video or phone calls. At different time points (T0 (baseline), T1 (16th week), T2 (32nd week), and T3 (48th week), we collected the breast cancer specific questionnaire (EORTC-BR23), which consisted of various functional scales (body image, sexual functioning, sexual enjoyment, future perspective) and symptomatic scales (systemic therapy side effects, breast symptoms, arm symptoms, upset by hair loss), and compared them between groups as well as within group.
Results
Out of 96 total patients, 82 were analyzed for T0-T3 (40 in group-I and 42 in group-II). In groups I and II, the mean age was 47.67±11.68 and 43.11±9.39, respectively. Yogic intervention resulted in a significant improvement in arm symptoms and side effects from T0 to T3 (p<0.001) and T1 to T3 (p<0.01) in group II, while group I also improved from T0 to T3 (p<0.05). The most significant difference was observed in Group-I (T0) vs. Group-II (T3). There was no significant difference observed in upset by hair loss, body image, breast symptoms, or future perspective.
Conclusions
The duration of yoga positively correlated with the systematic therapy side effects and improved their arm symptoms. This suggested that yogic intervention during therapy could be an effective complementary therapy.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2125P - Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study
Presenter: Alessio Cortellini
Session: Poster session 06
2126P - Exercise implementation into a clinic setting with 1.660 cancer patients: Real-world data from eight years oncological exercise therapy in Cologne (OTT)
Presenter: Timo Niels
Session: Poster session 06
2128P - exerCise discussion with Oncologist duriNg caNcEr ConsultaTion: The CONNECT study
Presenter: Sara Pilotto
Session: Poster session 06
2129P - Feasibility of a virtual exercise program to mitigate decline in physical function for advanced lung cancer patients
Presenter: Ying Wang, Sarah Yeo
Session: Poster session 06